Y54: Agents primarily affecting water-balance and mineral and uric acid metabolism
Y54.2: Carbonic-anhydrase inhibitors
Carbonic-anhydrase inhibitors are a type of medication that helps to manage conditions linked to an overproduction of fluid in the body. They work by reducing the activity of an enzyme called carbonic anhydrase, which is involved in the process of fluid production. This class of drugs is often used in the treatment of conditions such as glaucoma, a disease that increases pressure in the eye and can lead to vision loss if not properly managed. Additionally, they can help manage symptoms in conditions where there is excessive fluid retention in the body, like certain types of heart disease or kidney disorders. Like all medications, carbonic anhydrase inhibitors can carry potential side effects; these may include fatigue, increased urination, loss of appetite, or a metallic taste in the mouth. It's important to discuss any concerns about side effects with your healthcare provider.
Patient Disclaimer
The information provided on this page is for general educational purposes only. It is not intended for self-diagnosis and does not replace professional medical advice. Always consult your doctor or a qualified healthcare provider with any questions or concerns about your health.
If you see an ICD diagnosis code (e.g., on a medical report), be aware that doctors may also include additional indicators to express diagnostic certainty. Only a healthcare professional can interpret these codes accurately in the context of your individual case.
For a complete understanding of your condition and what the diagnosis means for you, please speak directly with your doctor.